These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Estimation of plasma potassium, renin and aldosterone in the diagnosis of primary hyperaldosteronism; the role of spironolactone in the treatment of this syndrome. Brown JJ; Chinn RH; Dusterdieck G; Fraser R; Lever AF; Robertson JI; Tree M J Endocrinol; 1969 Jan; 43(1):iv-v. PubMed ID: 5773780 [No Abstract] [Full Text] [Related]
23. [New potentialities in the treatment of idiopathic hyperaldosteronism]. Podzolkov VI; Rodionov AV Klin Med (Mosk); 2004; 82(6):34-8. PubMed ID: 15344688 [TBL] [Abstract][Full Text] [Related]
31. [Aldosterone and aldosterone antagonists in surgery]. Oelert H Anaesthesist; 1971 Jun; 20(6):205-11. PubMed ID: 4943021 [No Abstract] [Full Text] [Related]
32. Two cases of pseudoaldosteronism (Liddle's syndrome) in siblings. Ono F; Harada H; Komatsu K; Saijo K; Miyoshi K Endocrinol Jpn; 1975 Apr; 22(2):163-7. PubMed ID: 1149690 [TBL] [Abstract][Full Text] [Related]
33. Combination diuretic drug therapy. Reubi FC Cardiovasc Clin; 1971; 2(3):197-210. PubMed ID: 4950425 [No Abstract] [Full Text] [Related]
34. [Primary hyperaldosteronism]. Menard J; Safar M; Weil B; Milliez P Bull Acad Natl Med; 1970 Apr; 154(13):258-60. PubMed ID: 4913677 [No Abstract] [Full Text] [Related]
35. [Spironolactones in the treatment of arterial hypertension of different etiologies associated with hyperaldosteronism]. Chikhladze NM Ter Arkh; 1981; 53(6):74-8. PubMed ID: 7281037 [No Abstract] [Full Text] [Related]
36. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. Brilla CG; Matsubara LS; Weber KT J Mol Cell Cardiol; 1993 May; 25(5):563-75. PubMed ID: 8377216 [TBL] [Abstract][Full Text] [Related]
37. [Secondary aldosteronism following surgery using the heart-lung machine and its regulation with Aldactone]. Gleichmann U; Bostroem B; Kreuzer H; Löhr B Anaesthesist; 1965 Dec; 14(12):355-9. PubMed ID: 5870012 [No Abstract] [Full Text] [Related]
38. [Steroid spirolactones--antagonists of mineralocorticoids]. Linèt O Cesk Farm; 1969 Jun; 18(4):218-26. PubMed ID: 4895579 [No Abstract] [Full Text] [Related]
39. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?]. Brilla CG; Schencking M; Scheer C; Rupp H Praxis (Bern 1994); 1997 Apr; 86(14):566-74. PubMed ID: 9198851 [TBL] [Abstract][Full Text] [Related]
40. [Modification of ionic balance by an injectable antialdosterone drug in resuscitation]. Roquefeuil B; Nord D; Viguie E; Fischbach C Agressologie; 1972; 13(3):185-94. PubMed ID: 5086033 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]